Tacrolimus was developed for the management of graft rejections when the conventional immunosuppressants were a failure in some patients. This drug was later found to be effective in various dermatological disorders which had a pathological immune basis. Tacrolimus being an immunomodulator has been found to be effective in immunological skin disorders when applied topically.